Approach to Helicobacter pylori infection in paediatric population
Abstract
Infection with Helicobacter pylori significantly decrease in its prevalence recorded in recent years, especially in the developed world and dropped below 20%. In majority of cases in children Helicobacter pylori cause asymptomatic chronic gastritis. Systematic reviews and metanalysis showed that recurrent abdominal pains in children are not associated with bacterial infection. Therefore "test and treat" strategy is not recommended in pediatric population. Eradication therapy should be prescribed according to antimicrobial sensitivity of the bacterial strain obtained during endoscopy. In the article are presented recommendations and guidelines of the joint North American and European Society of Pediatric Gastroenterology Hepatology and Nutrition (NASPGHAN, ESPGHAN) published this year, based on the systemic review of published studies from that field.
Downloads
References
Jones NL, Koletzko S, Goodman K, Bontems P, Cadranel S, Casswall T, et al.; ESPGHAN, NASPGHAN. Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016). J Pediatr Gastroenterol Nutr. 2017 Jun;64(6):991–1003. https://doi.org/10.1097/MPG.0000000000001594 PMID:28541262
Homan M, Hojsak I, Kolaček S. Helicobacter pylori in pediatrics. Helicobacter. 2012 Sep;17 Suppl 1:43–8. https://doi.org/10.1111/j.1523-5378.2012.00982.x PMID:22958155
Sierra MS, Hastings EV, Goodman KJ. What do we know about benefits of H. pylori treatment in childhood? Gut Microbes. 2013 Nov-Dec;4(6):549–67. https://doi.org/10.4161/gmic.27000 PMID:24280768
Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut. 2010 Aug;59(8):1143–53. https://doi.org/10.1136/gut.2009.192757 PMID:20525969
Spee LA, Madderom MB, Pijpers M, van Leeuwen Y, Berger MY. Association between helicobacter pylori and gastrointestinal symptoms in children. Pediatrics. 2010 Mar;125(3):e651–69. https://doi.org/10.1542/peds.2010-0941 PMID:20156901
Holster IL, Vila AM, Caudri D, den Hoed CM, Perez-Perez GI, Blaser MJ, et al. The impact of Helicobacter pylori on atopic disorders in childhood. Helicobacter. 2012 Jun;17(3):232–7. https://doi.org/10.1111/j.1523-5378.2012.00934.x PMID:22515362
Feydt-Schmidt A, Kindermann A, Konstantopoulos N, Demmelmair H, Ballauff A, Findeisen A, et al. Reinfection rate in children after successful Helicobacter pylori eradication. Eur J Gastroenterol Hepatol. 2002 Oct;14(10):1119–23. https://doi.org/10.1097/00042737-200210000-00013 PMID:12362103
Bontems P, Kalach N, Vanderpas J, Iwanczak B, Casswall T, Koletzko S, et al. Helicobacter pylori Infection in European children with gastro-duodenal ulcers and erosions. Pediatr Infect Dis J. 2013 Dec;32(12):1324–9. https://doi.org/10.1097/INF.0000000000000005 PMID:24569306
Brito HS, Braga JA, Loggetto SR, Machado RS, Granato CF, Kawakami E. Helicobacter pylori infection & immune thrombocytopenic purpura in children and adolescents: A randomized controlled trial. Platelets. 2015;26(4):336–41. https://doi.org/10.3109/09537104.2014.911836 PMID:24832381
Russo G, Miraglia V, Branciforte F, Matarese SM, Zecca M, Bisogno G, et al.; AIEOP-ITP Study Group. Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study. Pediatr Blood Cancer. 2011 Feb;56(2):273–8. https://doi.org/10.1002/pbc.22770 PMID:20830773
Ferrara M, Capozzi L, Russo R. Effect of Helicobacter pylori eradication on platelet count in children with chronic idiopathic thrombocytopenic purpura. Hematology. 2009 Oct;14(5):282–5. https://doi.org/10.1179/102453309X12473408860181 PMID:19843384
Homan M, Luzar B, Kocjan BJ, Orel R, Mocilnik T, Shrestha M, et al. Prevalence and clinical relevance of cagA, vacA, and iceA genotypes of Helicobacter pylori isolated from Slovenian children. J Pediatr Gastroenterol Nutr. 2009 Sep;49(3):289–96. https://doi.org/10.1097/MPG.0b013e31818f09f2 PMID:19525870
Homan M, Šterbenc A, Kocjan BJ, Luzar B, Zidar N, Orel R, et al. Prevalence of the Helicobacter pylori babA2 gene and correlation with the degree of gastritis in infected Slovenian children. Antonie van Leeuwenhoek. 2014 Oct;106(4):637–45. https://doi.org/10.1007/s10482-014-0234-0 PMID:25055876
Thankachan P, Muthayya S, Sierksma A, Eilander A, Thomas T, Duchateau GS, et al. Helicobacter pylori infection does not influence the efficacy of iron and vitamin B(12) fortification in marginally nourished Indian children. Eur J Clin Nutr. 2010 Oct;64(10):1101–7. https://doi.org/10.1038/ejcn.2010.126 PMID:20683455
Goodman KJ, Correa P, Mera R, Yepez MC, Cerón C, Campo C, et al. Effect of Helicobacter pylori infection on growth velocity of school-age Andean children. Epidemiology. 2011 Jan;22(1):118–26. https://doi.org/10.1097/EDE.0b013e3181fe7e31 PMID:21068668
Rimbara E, Sasatsu M, Graham DY. PCR detection of Helicobacter pylori in clinical samples. Methods Mol Biol. 2013;943:279–87. https://doi.org/10.1007/978-1-60327-353-4_19 PMID:23104297
Leal YA, Flores LL, Fuentes-Pananá EM, Cedillo-Rivera R, Torres J. 13C-urea breath test for the diagnosis of Helicobacter pylori infection in children: a systematic review and meta-analysis. Helicobacter. 2011 Aug;16(4):327–37. https://doi.org/10.1111/j.1523-5378.2011.00863.x PMID:21762274
Graham DY, Lee YC, Wu MS. Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence. Clin Gastroenterol Hepatol. 2014;12(2):177–86 e3; Discussion e12–3. https://doi.org/10.1016/j.cgh.2013.05.028 PMID: 23751282
Butenko T, Jeverica S, Orel R, Homan M. Antibacterial resistance and the success of tailored triple therapy in Helicobacter pylori strains isolated from Slovenian children. Helicobacter. 2017;22(5):e12400. https://doi.org/10.1111/hel.12400 PMID: 28653787
Schwarzer A, Bontems P, Urruzuno P, Kalach N, Iwanczak B, Roma-Giannikou E, et al. Sequential Therapy for Helicobacter pylori Infection in Treatment-naïve Children. Helicobacter. 2016 Apr;21(2):106–13. https://doi.org/10.1111/hel.12240 PMID:26123402
Tepeš B, Vujasinović M, Šeruga M, Stefanovič M, Forte A, Jeverica S. Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication. Eur J Gastroenterol Hepatol. 2016 Jun;28(6):676–83. https://doi.org/10.1097/MEG.0000000000000590 PMID:26862930
Jeverica S, Tepeš B, Ihan A, Skvarč M. Primarna odpornost bakterije Helicobacter pylori. Zdrav Vestn. 2010;79(1):25–30.
Zhu R, Chen K, Zheng YY, Zhang HW, Wang JS, Xia YJ, et al. Meta-analysis of the efficacy of probiotics in Helicobacter pylori eradication therapy. World J Gastroenterol. 2014 Dec;20(47):18013–21. https://doi.org/10.3748/wjg.v20.i47.18013 PMID:25548501
Molina-Infante J, Lucendo AJ, Angueira T, Rodriguez-Tellez M, Perez-Aisa A, Balboa A, et al.; European Registry on H. pylori management (Hp‐EuReg). Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study. Aliment Pharmacol Ther. 2015 Mar;41(6):581–9. https://doi.org/10.1111/apt.13069 PMID:25776067
Koletzko S, Jones NL, Goodman KJ, Gold B, Rowland M, Cadranel S, et al.; H pylori Working Groups of ESPGHAN and NASPGHAN. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):230–43. PMID:21558964
Zeng M, Mao XH, Li JX, Tong WD, Wang B, Zhang YJ, et al. Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2015 Oct;386(10002):1457–64. https://doi.org/10.1016/S0140-6736(15)60310-5 PMID:26142048
Copyright (c) 2018 Slovenian Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
